These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7044708)

  • 1. Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease.
    Steele P; Gold F
    Chest; 1982 Jul; 82(1):40-3. PubMed ID: 7044708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of acebutolol in chronic stable angina using single-blind and randomized double-blind protocol.
    Lee G; DeMaria AN; Favrot L; Hermanovich J; Kozina J; Krieg P; Kimchi A; Laddu A; Mason DT
    J Clin Pharmacol; 1982; 22(8-9):371-8. PubMed ID: 6813360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute effects of oral acebutolol on exercise tolerance in patients with stable angina pectoris (author's transl)].
    Scrutinio D; De Toma L; Mangini S; Boscia F; Quagliara D; De Nicolò M; Rizzon P
    G Ital Cardiol; 1981; 11(3):364-72. PubMed ID: 7026336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation between clinical and exercise responsiveness to beta-blockade in angina.
    Tremblay G; Biron P; Proulx A
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):508-12. PubMed ID: 32144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acebutolol in angina pectoris: objective assessment using graded treadmill testing.
    Kimchi A; Gotsman MS; Lewis BS
    Isr J Med Sci; 1978 Sep; 14(9):941-7. PubMed ID: 363642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
    Winsor T; Berger HJ
    Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acebutolol on chronic stable angina pectoris. A placebo-controlled, double-blind, randomized crossover study.
    DiBianco R; Singh S; Singh JB; Katz RJ; Bortz R; Gottdiener JS; Spodick DH; Laddu AR; Fletcher RD
    Circulation; 1980 Dec; 62(6):1179-87. PubMed ID: 6777070
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose acebutolol given once daily in the treatment of chronic angina pectoris.
    Piña IL; Smith EV; Weidler DJ
    J Clin Pharmacol; 1988 May; 28(5):427-30. PubMed ID: 3392240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
    Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the beta-blocking drug acebutolol in angina pectoris.
    Rod JL; Admon D; Kimchi A; Gotsman MS; Lewis BS
    Am Heart J; 1979 Nov; 98(5):604-12. PubMed ID: 495406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential antianginal responsiveness to acebutolol.
    Biron P; Tremblay G
    Eur J Clin Pharmacol; 1975; 8(1):15-9. PubMed ID: 786672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acebutolol and left ventricular function: assessment by radionuclide angiography.
    Katz RJ; DiBianco R; Singh S; Bortz R; Bates HR; Sauerbrunn B; Laddu AR; Fletcher RD
    Clin Pharmacol Ther; 1981 Feb; 29(2):149-54. PubMed ID: 7460480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind study of pindolol in patients with stable angina pectoris.
    Harston WE; Friesinger GC
    Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nifedipine, acebutolol, and their association on exercise tolerance in patients with effort angina.
    De Ponti C; De Biase AM; Pirelli S; Cataldo G; Salvadé P; Lanocita M; Carù B
    Cardiology; 1981; 68 Suppl 2():195-9. PubMed ID: 7032697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acebutolol on dynamic ischemic ECG changes: a study using ambulatory twenty-four-hour ECG monitoring.
    Admon D; Kamchi A; Lewis BS; Gotsman MS
    Isr J Med Sci; 1979 Mar; 15(3):207-11. PubMed ID: 37190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W; Park J; DiBianco R; Singh SN; Katz RJ; Fletcher R
    Chest; 1981 Oct; 80(4):425-30. PubMed ID: 6791883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose and lipid metabolism during acebutolol and propranolol therapy of angina in nondiabetic patients.
    Birnbaum J; DiBianco R; Becker KL; Muesing R; Costello RB; Singh SN; Gottdiener JS; Fletcher RD
    Clin Pharmacol Ther; 1983 Mar; 33(3):294-300. PubMed ID: 6337762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of acebutolol in chronic stable angina: drug-induced positive antinuclear antibody.
    Bloomquist JN; Laddu A; Engler R
    J Cardiovasc Pharmacol; 1984; 6(5):735-8. PubMed ID: 6209474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac ischemia on exercise. Effect of nifedipine and acebutolol singly and in combination (author's transl)].
    Strasser R; Klepzig H
    MMW Munch Med Wochenschr; 1981 Aug; 123(35):1303-6. PubMed ID: 6793850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary effects of acebutolol, a "cardioselective" beta adrenergic blocking agent.
    DiBianco R; Dickie KJ; Singh S; Katz RJ; Costello RB; Gottdiene JS; Laddu AR; Fletcher RD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):1-7. PubMed ID: 6120142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.